BioHarvest Sciences Inc.

BHST Consumer Defensive Packaged Foods

BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

1.85 0.15 +8.82%
Market cap
$38.5M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
0.33
Beneish M
−2.41
Dividend safety
n/a

BioHarvest Sciences Inc. (BHST) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, BioHarvest Sciences Inc. (BHST) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from −9.8× (October 2020) to 468× (February 2021); the current reading is higher than 25% of that period. That is below the Packaged Foods industry median of 0.9× and below the Consumer Defensive sector median of 1.0×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (46.04%)
FY2024 4.0× (43.81%)
FY2023 7.2× (61.13%)
FY2022 18.5× (74.61%)
FY2021 72.7× —
FY2020 −0.1× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.5× (36.10%)
Mar 2026 2.3× 5.51%
Dec 2025 2.2× (55.23%)
Sep 2025 4.9× 19.44%
24 more quarters

Against its own ten years

Low −9.8× High 468×
Ten-year median 4.8×
Current reading's percentile 2

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BHST